System Transmission

Top Signal

100#1 JOB

Activity

2186Ripe

+957 today

System

Livenow

Terminal Asset View

stockNASDAQ

ONCO

$0.54-5.17%

Onconetix Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

5Overripe

Live Analysis Active

Company Mission

Onconetix creates targeted cancer therapies that aim to treat specific types of cancer cells. Doctors and hospitals would use these treatments for patients with certain cancers. The company makes money by conducting clinical trials and hopes to earn revenue from drug sales if treatments get approved by regulators.

ONC

Industry Context

Biotechnology companies develop medical treatments through scientific research. This sector experiences significant price swings based on clinical trial results and regulatory approvals from agencies like the FDA. Companies without approved products rely heavily on investor funding for research.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

45Matrix

Market Momentum

35.2— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.1x— Normal Volume

Today's Change

-5.17%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ONCO across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:26 AM UTC

As-of 03-15-2026 09:11 UTC

Develops cancer drugs and sells them to hospitals and clinics, earning money from treatment sales and research partnerships.

Weekly price range is narrowing near recent lows, suggesting a potential breakout or breakdown is approaching.

Biotech sector volatility remains high as FDA decisions approach, creating uncertainty for clinical-stage companies, suggesting clinical-stage.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...